Reagents.

Ended Awarded

Contract number
HT009026FK008
Awardee
Awarding agency
Obligated
$96,116

Award facts

Contract value 100% obligated
$96,116.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 6 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation for reagents, with a ceiling value of $96,116.41 and an award date of July 2, 2026. Performance is scheduled to conclude by September 30, 2026, at Roche's facility in Castleton, Indiana. The call carries no set-aside designation and is priced on a firm fixed-price basis. No parent BPA name is identified in the source; the call's parent vehicle designation is not explicitly stated.

Quick answers

Who was awarded contract HT009026FK008?

HT009026FK008 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on July 2, 2026.

How much is contract HT009026FK008 worth?

The government has obligated $96,116 on HT009026FK008.

Is contract HT009026FK008 an order under another contract?

Yes. HT009026FK008 is a BPA call under FA301625A0005, a blanket purchase agreement.

Was contract HT009026FK008 competed?

The extent of competition for HT009026FK008 was competed under sap. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award